Dr Reddy’s Q4 Profit Crashes 86% on Impairment Charge

Dr Reddy's Laboratories reported an 86% year-on-year decline in Q4 net profit to Rs 221 crore, missing estimates due to a major impairment charge related to its discontinued cancer therapy programme. The weak performance marked the drugmaker’s second consecutive quarterly profit decline.